

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.20557988 |
| 2 | drug catabolic process (GO:0042737) | 6.71000829 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 6.34348975 |
| 4 | carnitine shuttle (GO:0006853) | 5.84377276 |
| 5 | lysine catabolic process (GO:0006554) | 5.78239791 |
| 6 | lysine metabolic process (GO:0006553) | 5.78239791 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 5.68020066 |
| 8 | * fatty acid beta-oxidation (GO:0006635) | 5.40196819 |
| 9 | regulation of sequestering of triglyceride (GO:0010889) | 5.28189786 |
| 10 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.12253821 |
| 11 | 2-oxoglutarate metabolic process (GO:0006103) | 5.11039420 |
| 12 | omega-hydroxylase P450 pathway (GO:0097267) | 5.10040899 |
| 13 | oxidative demethylation (GO:0070989) | 5.08382928 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 5.05606653 |
| 15 | NADH metabolic process (GO:0006734) | 4.80126160 |
| 16 | * fatty acid oxidation (GO:0019395) | 4.77077020 |
| 17 | * lipid oxidation (GO:0034440) | 4.68998913 |
| 18 | * fatty acid catabolic process (GO:0009062) | 4.68248129 |
| 19 | carnitine transmembrane transport (GO:1902603) | 4.58813201 |
| 20 | valine metabolic process (GO:0006573) | 4.57122428 |
| 21 | aspartate family amino acid catabolic process (GO:0009068) | 4.54831997 |
| 22 | branched-chain amino acid catabolic process (GO:0009083) | 4.52432446 |
| 23 | acetyl-CoA metabolic process (GO:0006084) | 4.52254285 |
| 24 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.51964442 |
| 25 | carnitine transport (GO:0015879) | 4.46041215 |
| 26 | amino-acid betaine transport (GO:0015838) | 4.46041215 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.45635693 |
| 28 | tricarboxylic acid metabolic process (GO:0072350) | 4.41224508 |
| 29 | drug metabolic process (GO:0017144) | 4.40026042 |
| 30 | biotin metabolic process (GO:0006768) | 4.38302220 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36693791 |
| 32 | short-chain fatty acid metabolic process (GO:0046459) | 4.35526369 |
| 33 | cellular glucuronidation (GO:0052695) | 4.35236507 |
| 34 | sarcomere organization (GO:0045214) | 4.29776719 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 4.26556145 |
| 36 | branched-chain amino acid metabolic process (GO:0009081) | 4.24014789 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.23766897 |
| 38 | succinate metabolic process (GO:0006105) | 4.18302229 |
| 39 | * regulation of fatty acid oxidation (GO:0046320) | 4.16591684 |
| 40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.15061150 |
| 41 | regulation of cofactor metabolic process (GO:0051193) | 4.13893290 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 4.13893290 |
| 43 | * monocarboxylic acid catabolic process (GO:0072329) | 4.13086468 |
| 44 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09286495 |
| 45 | regulation of protein activation cascade (GO:2000257) | 4.07790897 |
| 46 | glucuronate metabolic process (GO:0019585) | 4.04349423 |
| 47 | uronic acid metabolic process (GO:0006063) | 4.04349423 |
| 48 | positive regulation of fatty acid oxidation (GO:0046321) | 4.03538571 |
| 49 | L-phenylalanine metabolic process (GO:0006558) | 4.00191985 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.00191985 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.96587255 |
| 52 | negative regulation of protein activation cascade (GO:2000258) | 3.91656606 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.90031899 |
| 54 | L-phenylalanine catabolic process (GO:0006559) | 3.90031899 |
| 55 | regulation of complement activation (GO:0030449) | 3.88398571 |
| 56 | * amino-acid betaine metabolic process (GO:0006577) | 3.85414054 |
| 57 | negative regulation of complement activation (GO:0045916) | 3.83898281 |
| 58 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.79965535 |
| 59 | cardiac myofibril assembly (GO:0055003) | 3.75541054 |
| 60 | oxidative phosphorylation (GO:0006119) | 3.74341787 |
| 61 | kynurenine metabolic process (GO:0070189) | 3.73808065 |
| 62 | quaternary ammonium group transport (GO:0015697) | 3.69887526 |
| 63 | S-adenosylmethionine metabolic process (GO:0046500) | 3.67704952 |
| 64 | * carnitine metabolic process (GO:0009437) | 3.67633358 |
| 65 | bile acid metabolic process (GO:0008206) | 3.67219214 |
| 66 | ketone body metabolic process (GO:1902224) | 3.66485037 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.66184741 |
| 68 | oxaloacetate metabolic process (GO:0006107) | 3.64237137 |
| 69 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.62391729 |
| 70 | regulation of sulfur metabolic process (GO:0042762) | 3.59677200 |
| 71 | ethanol oxidation (GO:0006069) | 3.56387493 |
| 72 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.52987258 |
| 73 | amine catabolic process (GO:0009310) | 3.50837384 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.50837384 |
| 75 | negative regulation of fibrinolysis (GO:0051918) | 3.50661852 |
| 76 | cysteine metabolic process (GO:0006534) | 3.50647545 |
| 77 | aromatic amino acid family catabolic process (GO:0009074) | 3.49923210 |
| 78 | flavonoid metabolic process (GO:0009812) | 3.49903168 |
| 79 | sulfur amino acid catabolic process (GO:0000098) | 3.49435995 |
| 80 | complement activation, alternative pathway (GO:0006957) | 3.47472482 |
| 81 | respiratory electron transport chain (GO:0022904) | 3.45358238 |
| 82 | actin-myosin filament sliding (GO:0033275) | 3.44133144 |
| 83 | muscle filament sliding (GO:0030049) | 3.44133144 |
| 84 | glycine metabolic process (GO:0006544) | 3.43325964 |
| 85 | drug transmembrane transport (GO:0006855) | 3.43163331 |
| 86 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.37732319 |
| 87 | alkaloid metabolic process (GO:0009820) | 3.37663538 |
| 88 | * organic acid catabolic process (GO:0016054) | 3.36046647 |
| 89 | * carboxylic acid catabolic process (GO:0046395) | 3.36046647 |
| 90 | electron transport chain (GO:0022900) | 3.35354288 |
| 91 | myofibril assembly (GO:0030239) | 3.34924937 |
| 92 | ethanol metabolic process (GO:0006067) | 3.33254109 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.32518430 |
| 94 | serine family amino acid catabolic process (GO:0009071) | 3.26442362 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.24205338 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.23676293 |
| 97 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.22448997 |
| 98 | tryptophan catabolic process (GO:0006569) | 3.19296908 |
| 99 | indole-containing compound catabolic process (GO:0042436) | 3.19296908 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 3.19296908 |
| 101 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.18767628 |
| 102 | alpha-amino acid catabolic process (GO:1901606) | 3.17688900 |
| 103 | intracellular lipid transport (GO:0032365) | 3.15361213 |
| 104 | phenylpropanoid metabolic process (GO:0009698) | 3.14032910 |
| 105 | arginine metabolic process (GO:0006525) | 3.13550307 |
| 106 | L-methionine salvage (GO:0071267) | 3.12931679 |
| 107 | L-methionine biosynthetic process (GO:0071265) | 3.12931679 |
| 108 | amino acid salvage (GO:0043102) | 3.12931679 |
| 109 | acyl-CoA metabolic process (GO:0006637) | 3.11538622 |
| 110 | thioester metabolic process (GO:0035383) | 3.11538622 |
| 111 | aromatic amino acid family metabolic process (GO:0009072) | 3.09311357 |
| 112 | bile acid and bile salt transport (GO:0015721) | 3.09279055 |
| 113 | homocysteine metabolic process (GO:0050667) | 3.09028800 |
| 114 | acyl-CoA biosynthetic process (GO:0071616) | 3.08939934 |
| 115 | thioester biosynthetic process (GO:0035384) | 3.08939934 |
| 116 | benzene-containing compound metabolic process (GO:0042537) | 3.08730252 |
| 117 | cellular amino acid catabolic process (GO:0009063) | 3.07512790 |
| 118 | intestinal cholesterol absorption (GO:0030299) | 3.07416069 |
| 119 | bile acid biosynthetic process (GO:0006699) | 3.07318954 |
| 120 | arginine catabolic process (GO:0006527) | 3.07013451 |
| 121 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.06430655 |
| 122 | fibrinolysis (GO:0042730) | 3.05940361 |
| 123 | plasma lipoprotein particle clearance (GO:0034381) | 3.04439441 |
| 124 | phospholipid homeostasis (GO:0055091) | 3.03960484 |
| 125 | tryptophan metabolic process (GO:0006568) | 3.01401042 |
| 126 | cardiac muscle cell development (GO:0055013) | 3.01286611 |
| 127 | positive regulation of lipid storage (GO:0010884) | 2.99676923 |
| 128 | cardiac muscle contraction (GO:0060048) | 2.99491423 |
| 129 | triglyceride homeostasis (GO:0070328) | 2.97116803 |
| 130 | acylglycerol homeostasis (GO:0055090) | 2.97116803 |
| 131 | organic cation transport (GO:0015695) | 2.96697920 |
| 132 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.95135154 |
| 133 | response to mercury ion (GO:0046689) | 2.94182857 |
| 134 | ATP synthesis coupled proton transport (GO:0015986) | 2.92469407 |
| 135 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.92469407 |
| 136 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.91913534 |
| 137 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.91761734 |
| 138 | retinal metabolic process (GO:0042574) | 2.91269515 |
| 139 | fatty acid homeostasis (GO:0055089) | 2.91210347 |
| 140 | negative regulation of sterol transport (GO:0032372) | 2.90708765 |
| 141 | negative regulation of cholesterol transport (GO:0032375) | 2.90708765 |
| 142 | regulation of relaxation of muscle (GO:1901077) | 2.90554752 |
| 143 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.90365603 |
| 144 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.85085623 |
| 145 | xenobiotic metabolic process (GO:0006805) | 2.84237015 |
| 146 | dopamine transport (GO:0015872) | 2.81071688 |
| 147 | response to nitrosative stress (GO:0051409) | 2.80451241 |
| 148 | chemical homeostasis within a tissue (GO:0048875) | 2.78178569 |
| 149 | serine family amino acid metabolic process (GO:0009069) | 2.77018893 |
| 150 | negative regulation of humoral immune response (GO:0002921) | 2.73009825 |
| 151 | protein K11-linked deubiquitination (GO:0035871) | 2.71177230 |
| 152 | primary alcohol metabolic process (GO:0034308) | 2.70242628 |
| 153 | regulation of hexokinase activity (GO:1903299) | 2.63438362 |
| 154 | regulation of glucokinase activity (GO:0033131) | 2.63438362 |
| 155 | methionine biosynthetic process (GO:0009086) | 2.62926428 |
| 156 | drug transport (GO:0015893) | 2.62506759 |
| 157 | regulation of triglyceride metabolic process (GO:0090207) | 2.62141631 |
| 158 | protein carboxylation (GO:0018214) | 2.61844507 |
| 159 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.61844507 |
| 160 | sodium-independent organic anion transport (GO:0043252) | 2.60930981 |
| 161 | negative regulation of hemostasis (GO:1900047) | 2.58658907 |
| 162 | negative regulation of blood coagulation (GO:0030195) | 2.58658907 |
| 163 | detection of light stimulus involved in visual perception (GO:0050908) | 2.55546452 |
| 164 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.55546452 |
| 165 | positive regulation of glycolytic process (GO:0045821) | 2.55179756 |
| 166 | regulation of acrosome reaction (GO:0060046) | 2.55128966 |
| 167 | coenzyme catabolic process (GO:0009109) | 2.54865019 |
| 168 | protein activation cascade (GO:0072376) | 2.54844810 |
| 169 | negative regulation of lipase activity (GO:0060192) | 2.52865038 |
| 170 | tyrosine metabolic process (GO:0006570) | 2.51813823 |
| 171 | regulation of hippo signaling (GO:0035330) | 2.51742770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.91819407 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.06218102 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.49824642 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.12077653 |
| 5 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.65952969 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.29761825 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.38156561 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.36477638 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12755688 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.94281015 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.84898269 |
| 12 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.74897502 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.64958420 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.56952674 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43013721 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.41690714 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.36087198 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.29281700 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.28157478 |
| 20 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21896406 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.16968768 |
| 22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.10584756 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.09757795 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.09696749 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.08208061 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01936887 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90951893 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90504137 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.88185880 |
| 30 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.87054184 |
| 31 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.87054184 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.83670257 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83478195 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82154128 |
| 35 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.75871687 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74985861 |
| 37 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69278039 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69144992 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66096920 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65390012 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.62334651 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61396002 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58795472 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58715628 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55921274 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54231189 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.48648983 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47183222 |
| 49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46767551 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.46127834 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45747513 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45747513 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45083404 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44810886 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43989606 |
| 56 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43422526 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.43421578 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43103264 |
| 59 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43047579 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42943737 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40072198 |
| 62 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38892810 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37763216 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37686349 |
| 65 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36712352 |
| 66 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35676594 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35049029 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34919914 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32242643 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31842431 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30925672 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30304213 |
| 73 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29271866 |
| 74 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28426384 |
| 75 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26680522 |
| 76 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26449340 |
| 77 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.26144823 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25318287 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24427629 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24249382 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23807029 |
| 82 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23293585 |
| 83 | EWS_26573619_Chip-Seq_HEK293_Human | 1.23271592 |
| 84 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22684412 |
| 85 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21482452 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21472159 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21301773 |
| 88 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.20817010 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19843218 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.19842273 |
| 91 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19473537 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18234364 |
| 93 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17975788 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17857512 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17776860 |
| 96 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17190621 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16342746 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16342746 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16154338 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15760261 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15656466 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14892311 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14103164 |
| 104 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13575745 |
| 105 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12582749 |
| 106 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12225725 |
| 107 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.11353071 |
| 108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11351602 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11191161 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10539671 |
| 111 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10329239 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09930099 |
| 113 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09374946 |
| 114 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08182646 |
| 115 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.07832427 |
| 116 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07629391 |
| 117 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07453123 |
| 118 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07215152 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07211861 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07211861 |
| 121 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06614188 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06450538 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06078504 |
| 124 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05572616 |
| 125 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05003712 |
| 126 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04700186 |
| 127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04371669 |
| 128 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04264292 |
| 129 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04035233 |
| 130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03622965 |
| 131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03622965 |
| 132 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03441432 |
| 133 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03372415 |
| 134 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03077449 |
| 135 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02517893 |
| 136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01292167 |
| 137 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00704266 |
| 138 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99316035 |
| 139 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97149102 |
| 140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96718616 |
| 141 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96583771 |
| 142 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92448008 |
| 143 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91468597 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90175699 |
| 145 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89907149 |
| 146 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89805422 |
| 147 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87445975 |
| 148 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86521669 |
| 149 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85524540 |
| 150 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84563392 |
| 151 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.83227211 |
| 152 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83066543 |
| 153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81052461 |
| 154 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81050141 |
| 155 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.79975186 |
| 156 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79641762 |
| 157 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77367824 |
| 158 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76751883 |
| 159 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76279489 |
| 160 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76110444 |
| 161 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75475422 |
| 162 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75255924 |
| 163 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74547088 |
| 164 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73771435 |
| 165 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.72137046 |
| 166 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.70749536 |
| 167 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.70737222 |
| 168 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.70208749 |
| 169 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69818724 |
| 170 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69419940 |
| 171 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69135516 |
| 172 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69128363 |
| 173 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68708271 |
| 174 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68283537 |
| 175 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.67806886 |
| 176 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.67620339 |
| 177 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67280227 |
| 178 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.67031257 |
| 179 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.66562330 |
| 180 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66542606 |
| 181 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.66061032 |
| 182 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65759761 |
| 183 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.65660801 |
| 184 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.65586181 |
| 185 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.64688874 |
| 186 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64226105 |
| 187 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63601735 |
| 188 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63561058 |
| 189 | MAF_26560356_Chip-Seq_TH1_Human | 0.62160284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.05599542 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.05143215 |
| 3 | MP0005360_urolithiasis | 3.95074557 |
| 4 | MP0003646_muscle_fatigue | 3.85208581 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.48251298 |
| 6 | MP0005365_abnormal_bile_salt | 3.14961375 |
| 7 | MP0002876_abnormal_thyroid_physiology | 3.04973079 |
| 8 | * MP0005085_abnormal_gallbladder_physiolo | 3.01988031 |
| 9 | MP0004130_abnormal_muscle_cell | 3.01033863 |
| 10 | MP0005330_cardiomyopathy | 2.91020721 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.89103343 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.84189837 |
| 13 | MP0000751_myopathy | 2.71206994 |
| 14 | MP0003011_delayed_dark_adaptation | 2.68952697 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.61524305 |
| 16 | MP0005670_abnormal_white_adipose | 2.49955610 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.43800039 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.43287620 |
| 19 | MP0000749_muscle_degeneration | 2.35274597 |
| 20 | MP0009840_abnormal_foam_cell | 2.31850593 |
| 21 | MP0003868_abnormal_feces_composition | 2.28310476 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.26073072 |
| 23 | MP0005666_abnormal_adipose_tissue | 2.23794336 |
| 24 | * MP0005332_abnormal_amino_acid | 2.17059667 |
| 25 | MP0008775_abnormal_heart_ventricle | 2.11069728 |
| 26 | MP0004087_abnormal_muscle_fiber | 2.08645558 |
| 27 | MP0003136_yellow_coat_color | 2.00951405 |
| 28 | MP0002972_abnormal_cardiac_muscle | 2.00710166 |
| 29 | MP0003252_abnormal_bile_duct | 1.98585278 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.91806268 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.91806268 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.89252126 |
| 33 | MP0003195_calcinosis | 1.88233414 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.82611831 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.76093167 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.71979227 |
| 37 | * MP0002118_abnormal_lipid_homeostasis | 1.68918696 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.68711299 |
| 39 | MP0005620_abnormal_muscle_contractility | 1.68663792 |
| 40 | MP0006138_congestive_heart_failure | 1.64588734 |
| 41 | MP0003221_abnormal_cardiomyocyte_apopto | 1.64582549 |
| 42 | MP0002971_abnormal_brown_adipose | 1.63208729 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.56417929 |
| 44 | MP0005083_abnormal_biliary_tract | 1.56016102 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.55141671 |
| 46 | MP0002269_muscular_atrophy | 1.52092529 |
| 47 | MP0003137_abnormal_impulse_conducting | 1.51343985 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.51088429 |
| 49 | * MP0000609_abnormal_liver_physiology | 1.50970621 |
| 50 | MP0003828_pulmonary_edema | 1.48947992 |
| 51 | MP0002106_abnormal_muscle_physiology | 1.47912444 |
| 52 | MP0003879_abnormal_hair_cell | 1.43531241 |
| 53 | MP0004484_altered_response_of | 1.42531093 |
| 54 | MP0003186_abnormal_redox_activity | 1.41435724 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.41189625 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.39275082 |
| 57 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.36850799 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.34288548 |
| 59 | * MP0009643_abnormal_urine_homeostasis | 1.34246375 |
| 60 | MP0005451_abnormal_body_composition | 1.33354041 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 1.33309728 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.31939275 |
| 63 | MP0000747_muscle_weakness | 1.31275108 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.29551477 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 1.26677306 |
| 66 | MP0002638_abnormal_pupillary_reflex | 1.25611830 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.25260389 |
| 68 | MP0000343_altered_response_to | 1.24329926 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.23588680 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.17647181 |
| 71 | MP0001968_abnormal_touch/_nociception | 1.16831439 |
| 72 | MP0008872_abnormal_physiological_respon | 1.14495575 |
| 73 | MP0000759_abnormal_skeletal_muscle | 1.13799099 |
| 74 | MP0005369_muscle_phenotype | 1.11900381 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.10971532 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 1.09576044 |
| 77 | MP0005647_abnormal_sex_gland | 1.07630877 |
| 78 | MP0004043_abnormal_pH_regulation | 1.06155639 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.04982211 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 1.04548292 |
| 81 | MP0004085_abnormal_heartbeat | 1.03303932 |
| 82 | MP0002108_abnormal_muscle_morphology | 1.02219524 |
| 83 | MP0002102_abnormal_ear_morphology | 1.02096180 |
| 84 | MP0009745_abnormal_behavioral_response | 1.01846451 |
| 85 | MP0005535_abnormal_body_temperature | 1.01428904 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.98789732 |
| 87 | MP0003959_abnormal_lean_body | 0.98780285 |
| 88 | MP0005448_abnormal_energy_balance | 0.98659193 |
| 89 | MP0005266_abnormal_metabolism | 0.98594274 |
| 90 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98164242 |
| 91 | MP0002736_abnormal_nociception_after | 0.96386002 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.94003711 |
| 93 | MP0005334_abnormal_fat_pad | 0.93810316 |
| 94 | MP0005165_increased_susceptibility_to | 0.93531108 |
| 95 | * MP0002078_abnormal_glucose_homeostasis | 0.92307805 |
| 96 | MP0002168_other_aberrant_phenotype | 0.91473891 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.89058111 |
| 98 | MP0001764_abnormal_homeostasis | 0.88794572 |
| 99 | MP0009115_abnormal_fat_cell | 0.88744842 |
| 100 | MP0001756_abnormal_urination | 0.88735705 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.88152283 |
| 102 | MP0001853_heart_inflammation | 0.87969990 |
| 103 | MP0003045_fibrosis | 0.87847567 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.87225058 |
| 105 | MP0005645_abnormal_hypothalamus_physiol | 0.86184077 |
| 106 | MP0004147_increased_porphyrin_level | 0.85693581 |
| 107 | MP0002928_abnormal_bile_duct | 0.85515029 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.84456661 |
| 109 | MP0002127_abnormal_cardiovascular_syste | 0.83753896 |
| 110 | MP0000598_abnormal_liver_morphology | 0.81471394 |
| 111 | MP0004145_abnormal_muscle_electrophysio | 0.80103839 |
| 112 | MP0008995_early_reproductive_senescence | 0.80071779 |
| 113 | MP0002735_abnormal_chemical_nociception | 0.79763592 |
| 114 | MP0005253_abnormal_eye_physiology | 0.79763140 |
| 115 | MP0003724_increased_susceptibility_to | 0.79058432 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.78711754 |
| 117 | MP0003279_aneurysm | 0.77925256 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.77685167 |
| 119 | MP0004142_abnormal_muscle_tone | 0.76891964 |
| 120 | MP0002970_abnormal_white_adipose | 0.76217474 |
| 121 | MP0002272_abnormal_nervous_system | 0.75247863 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.73357177 |
| 123 | MP0009763_increased_sensitivity_to | 0.72885874 |
| 124 | MP0005187_abnormal_penis_morphology | 0.72246830 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.71439596 |
| 126 | MP0008469_abnormal_protein_level | 0.70301117 |
| 127 | MP0004233_abnormal_muscle_weight | 0.67079803 |
| 128 | MP0005395_other_phenotype | 0.67016303 |
| 129 | MP0000372_irregular_coat_pigmentation | 0.66918980 |
| 130 | MP0002064_seizures | 0.66785344 |
| 131 | * MP0009642_abnormal_blood_homeostasis | 0.66721217 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.66393599 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.66171102 |
| 134 | * MP0000266_abnormal_heart_morphology | 0.65979299 |
| 135 | MP0003953_abnormal_hormone_level | 0.64839337 |
| 136 | MP0004510_myositis | 0.64145461 |
| 137 | MP0005084_abnormal_gallbladder_morpholo | 0.63067161 |
| 138 | MP0003633_abnormal_nervous_system | 0.62658492 |
| 139 | MP0001970_abnormal_pain_threshold | 0.62569359 |
| 140 | MP0001661_extended_life_span | 0.61979057 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.61408491 |
| 142 | MP0009764_decreased_sensitivity_to | 0.60905629 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.60512058 |
| 144 | MP0002128_abnormal_blood_circulation | 0.60309808 |
| 145 | MP0009697_abnormal_copulation | 0.57466433 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.57085515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.00966885 |
| 2 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.91677967 |
| 3 | Myoglobinuria (HP:0002913) | 4.82740222 |
| 4 | Hyperglycinuria (HP:0003108) | 4.51595947 |
| 5 | Sudden death (HP:0001699) | 4.49884047 |
| 6 | Complement deficiency (HP:0004431) | 4.40958713 |
| 7 | Dicarboxylic aciduria (HP:0003215) | 4.37628183 |
| 8 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.37628183 |
| 9 | Hyperammonemia (HP:0001987) | 4.17521452 |
| 10 | Rhabdomyolysis (HP:0003201) | 4.13456444 |
| 11 | Ventricular tachycardia (HP:0004756) | 4.11754270 |
| 12 | Exercise-induced myalgia (HP:0003738) | 3.95055827 |
| 13 | Hepatic necrosis (HP:0002605) | 3.93372500 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 3.91589782 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91589782 |
| 16 | Ketoacidosis (HP:0001993) | 3.88045306 |
| 17 | Ketosis (HP:0001946) | 3.86619649 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.80518057 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79589256 |
| 20 | Hyperventilation (HP:0002883) | 3.69054965 |
| 21 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.67529768 |
| 22 | Exercise-induced muscle cramps (HP:0003710) | 3.64398691 |
| 23 | Palpitations (HP:0001962) | 3.50541463 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 3.46887589 |
| 25 | Increased muscle lipid content (HP:0009058) | 3.39807266 |
| 26 | Lipoatrophy (HP:0100578) | 3.36535642 |
| 27 | Xanthomatosis (HP:0000991) | 3.32506232 |
| 28 | Muscle fiber splitting (HP:0003555) | 3.30873137 |
| 29 | Thyroid-stimulating hormone excess (HP:0002925) | 3.25170753 |
| 30 | Cerebral edema (HP:0002181) | 3.24664205 |
| 31 | Hyperglycinemia (HP:0002154) | 3.22652338 |
| 32 | Nausea (HP:0002018) | 3.21739864 |
| 33 | Calf muscle hypertrophy (HP:0008981) | 3.13560825 |
| 34 | Fair hair (HP:0002286) | 3.13122140 |
| 35 | Abnormality of complement system (HP:0005339) | 3.09925030 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.09643089 |
| 37 | Atrial fibrillation (HP:0005110) | 3.07573700 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.06070926 |
| 39 | Proximal tubulopathy (HP:0000114) | 3.01171869 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 3.00594229 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.99975891 |
| 42 | Joint hemorrhage (HP:0005261) | 2.93543542 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.91960856 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 2.91562762 |
| 45 | Acute encephalopathy (HP:0006846) | 2.91138061 |
| 46 | Hyporeflexia of lower limbs (HP:0002600) | 2.89926013 |
| 47 | Deep venous thrombosis (HP:0002625) | 2.89056493 |
| 48 | Hepatocellular necrosis (HP:0001404) | 2.86545456 |
| 49 | Lethargy (HP:0001254) | 2.85587277 |
| 50 | Muscle fiber inclusion bodies (HP:0100299) | 2.84081884 |
| 51 | Metabolic acidosis (HP:0001942) | 2.82476973 |
| 52 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.82455284 |
| 53 | Primary atrial arrhythmia (HP:0001692) | 2.81590090 |
| 54 | Atrioventricular block (HP:0001678) | 2.80567682 |
| 55 | Supraventricular tachycardia (HP:0004755) | 2.73200565 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.72749449 |
| 57 | Type II lissencephaly (HP:0007260) | 2.70857930 |
| 58 | Supraventricular arrhythmia (HP:0005115) | 2.68634172 |
| 59 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.68558611 |
| 60 | Subaortic stenosis (HP:0001682) | 2.68558611 |
| 61 | Chronic hepatic failure (HP:0100626) | 2.68544993 |
| 62 | Renal cortical cysts (HP:0000803) | 2.67555176 |
| 63 | Increased connective tissue (HP:0009025) | 2.67294973 |
| 64 | Nemaline bodies (HP:0003798) | 2.64911559 |
| 65 | Hyperkalemia (HP:0002153) | 2.63519268 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.63102904 |
| 67 | Lactic acidosis (HP:0003128) | 2.62177161 |
| 68 | Abnormality of serum amino acid levels (HP:0003112) | 2.61726965 |
| 69 | Pancreatic cysts (HP:0001737) | 2.61098802 |
| 70 | Syncope (HP:0001279) | 2.60647870 |
| 71 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60527027 |
| 72 | Glomerulonephritis (HP:0000099) | 2.60251128 |
| 73 | Abnormality of the calf musculature (HP:0001430) | 2.58390495 |
| 74 | Conjunctival hamartoma (HP:0100780) | 2.57373627 |
| 75 | Gaze-evoked nystagmus (HP:0000640) | 2.55374859 |
| 76 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.54788968 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 2.54449204 |
| 78 | Inability to walk (HP:0002540) | 2.53919187 |
| 79 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.53128146 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 2.52146556 |
| 81 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.49636913 |
| 82 | Generalized hypopigmentation of hair (HP:0011358) | 2.49229206 |
| 83 | Heart block (HP:0012722) | 2.49054398 |
| 84 | Tubular atrophy (HP:0000092) | 2.48366716 |
| 85 | Tachypnea (HP:0002789) | 2.47819864 |
| 86 | Bundle branch block (HP:0011710) | 2.47183009 |
| 87 | Decreased circulating renin level (HP:0003351) | 2.45910128 |
| 88 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45739041 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.43507811 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.43207675 |
| 91 | Hyperalaninemia (HP:0003348) | 2.43207675 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.43207675 |
| 93 | Vomiting (HP:0002013) | 2.42814821 |
| 94 | Ventricular arrhythmia (HP:0004308) | 2.39532456 |
| 95 | Difficulty running (HP:0009046) | 2.39310373 |
| 96 | Abnormal atrioventricular conduction (HP:0005150) | 2.36272722 |
| 97 | Increased serum pyruvate (HP:0003542) | 2.36140856 |
| 98 | Abnormality of glycolysis (HP:0004366) | 2.36140856 |
| 99 | Increased CSF lactate (HP:0002490) | 2.35983428 |
| 100 | Abnormality of the ischium (HP:0003174) | 2.35354503 |
| 101 | Muscle stiffness (HP:0003552) | 2.34183917 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.30445263 |
| 103 | Pancreatic fibrosis (HP:0100732) | 2.28919290 |
| 104 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28418764 |
| 105 | Pigmentary retinal degeneration (HP:0001146) | 2.28377329 |
| 106 | True hermaphroditism (HP:0010459) | 2.27679261 |
| 107 | Abnormality of urine glucose concentration (HP:0011016) | 2.27643256 |
| 108 | Glycosuria (HP:0003076) | 2.27643256 |
| 109 | Abnormal drinking behavior (HP:0030082) | 2.24893946 |
| 110 | Polydipsia (HP:0001959) | 2.24893946 |
| 111 | Hypobetalipoproteinemia (HP:0003563) | 2.24694591 |
| 112 | EMG: myopathic abnormalities (HP:0003458) | 2.24661733 |
| 113 | Mitochondrial inheritance (HP:0001427) | 2.24202862 |
| 114 | Abnormal biliary tract physiology (HP:0012439) | 2.22691888 |
| 115 | Bile duct proliferation (HP:0001408) | 2.22691888 |
| 116 | Tubulointerstitial abnormality (HP:0001969) | 2.22529106 |
| 117 | Facial shape deformation (HP:0011334) | 2.21027596 |
| 118 | Potter facies (HP:0002009) | 2.21027596 |
| 119 | Tubulointerstitial nephritis (HP:0001970) | 2.19673304 |
| 120 | Delayed CNS myelination (HP:0002188) | 2.17889563 |
| 121 | Neoplasm of head and neck (HP:0012288) | 2.17609087 |
| 122 | Esophageal neoplasm (HP:0100751) | 2.17609087 |
| 123 | Gout (HP:0001997) | 2.15612881 |
| 124 | Hypoplastic ischia (HP:0003175) | 2.15056667 |
| 125 | Congenital stationary night blindness (HP:0007642) | 2.15046880 |
| 126 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14640750 |
| 127 | Large for gestational age (HP:0001520) | 2.13887788 |
| 128 | Multiple enchondromatosis (HP:0005701) | 2.12791045 |
| 129 | Neonatal respiratory distress (HP:0002643) | 2.12675560 |
| 130 | Nephritis (HP:0000123) | 2.12348532 |
| 131 | Spontaneous abortion (HP:0005268) | 2.12151082 |
| 132 | Fat malabsorption (HP:0002630) | 2.11588994 |
| 133 | Respiratory failure (HP:0002878) | 2.10854888 |
| 134 | Tubulointerstitial fibrosis (HP:0005576) | 2.10459354 |
| 135 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.10042866 |
| 136 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.10042866 |
| 137 | Methylmalonic aciduria (HP:0012120) | 2.09974981 |
| 138 | Abnormality of purine metabolism (HP:0004352) | 2.08165972 |
| 139 | Progressive macrocephaly (HP:0004481) | 2.07325648 |
| 140 | Abnormality of potassium homeostasis (HP:0011042) | 2.06969325 |
| 141 | Neonatal death (HP:0003811) | 2.06258185 |
| 142 | Hypokalemia (HP:0002900) | 2.04563250 |
| 143 | Prolonged partial thromboplastin time (HP:0003645) | 2.03137345 |
| 144 | Nephronophthisis (HP:0000090) | 2.02680182 |
| 145 | Molar tooth sign on MRI (HP:0002419) | 2.01399729 |
| 146 | Abnormality of midbrain morphology (HP:0002418) | 2.01399729 |
| 147 | Abnormality of the renal medulla (HP:0100957) | 2.00989126 |
| 148 | Broad-based gait (HP:0002136) | 2.00867705 |
| 149 | Hydroxyprolinuria (HP:0003080) | 2.00744690 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 2.00744690 |
| 151 | Epidermoid cyst (HP:0200040) | 2.00667319 |
| 152 | Arthropathy (HP:0003040) | 1.94081619 |
| 153 | Progressive inability to walk (HP:0002505) | 1.93600949 |
| 154 | Male pseudohermaphroditism (HP:0000037) | 1.93146412 |
| 155 | Blue irides (HP:0000635) | 1.91121838 |
| 156 | Polyuria (HP:0000103) | 1.90198563 |
| 157 | Decreased central vision (HP:0007663) | 1.89927212 |
| 158 | Distal arthrogryposis (HP:0005684) | 1.89804335 |
| 159 | Absent speech (HP:0001344) | 1.88821855 |
| 160 | Steatorrhea (HP:0002570) | 1.86772856 |
| 161 | Abnormality of nucleobase metabolism (HP:0010932) | 1.86383768 |
| 162 | Hypokalemic alkalosis (HP:0001949) | 1.83985768 |
| 163 | Abnormal urine output (HP:0012590) | 1.83944475 |
| 164 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83264973 |
| 165 | Attenuation of retinal blood vessels (HP:0007843) | 1.82415407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.43373907 |
| 2 | BCKDK | 5.24884077 |
| 3 | PDK3 | 3.91112868 |
| 4 | PDK4 | 3.91112868 |
| 5 | TRIB3 | 3.89947193 |
| 6 | TTN | 3.76913762 |
| 7 | WNK3 | 3.66084368 |
| 8 | PKN2 | 3.45165396 |
| 9 | LMTK2 | 2.82136369 |
| 10 | OBSCN | 2.71794448 |
| 11 | MYLK | 2.58698612 |
| 12 | PDK2 | 2.50368317 |
| 13 | TIE1 | 2.31187198 |
| 14 | CASK | 2.19816416 |
| 15 | PHKG1 | 2.19081466 |
| 16 | PHKG2 | 2.19081466 |
| 17 | NEK1 | 2.14955486 |
| 18 | CAMKK2 | 2.07195812 |
| 19 | STK24 | 1.97761462 |
| 20 | SIK1 | 1.89174279 |
| 21 | GRK1 | 1.85842978 |
| 22 | AKT3 | 1.84148510 |
| 23 | PIK3CA | 1.82361194 |
| 24 | MAP4K2 | 1.81549607 |
| 25 | ADRBK2 | 1.77156144 |
| 26 | FLT3 | 1.75643330 |
| 27 | NME2 | 1.75237533 |
| 28 | ERN1 | 1.73444971 |
| 29 | FGFR4 | 1.70690025 |
| 30 | PINK1 | 1.70647033 |
| 31 | PNCK | 1.69258040 |
| 32 | MAPK15 | 1.55780707 |
| 33 | DAPK2 | 1.55228557 |
| 34 | DMPK | 1.54988117 |
| 35 | MAPK13 | 1.54679692 |
| 36 | NEK9 | 1.53615274 |
| 37 | NTRK3 | 1.47007331 |
| 38 | KDR | 1.42560530 |
| 39 | BMPR1B | 1.38528679 |
| 40 | BLK | 1.36319484 |
| 41 | NUAK1 | 1.33479201 |
| 42 | MAP2K3 | 1.31668773 |
| 43 | WNK4 | 1.27495107 |
| 44 | PRKAA2 | 1.20732633 |
| 45 | OXSR1 | 1.20465936 |
| 46 | MARK1 | 1.19286724 |
| 47 | ILK | 1.17182048 |
| 48 | CAMK1G | 1.16330337 |
| 49 | TGFBR2 | 1.13439572 |
| 50 | MST1R | 1.12641986 |
| 51 | SGK2 | 1.10851935 |
| 52 | PRKCE | 1.10025815 |
| 53 | ACVR1B | 1.09755309 |
| 54 | MUSK | 1.07527421 |
| 55 | FER | 1.03824243 |
| 56 | IRAK1 | 1.02326163 |
| 57 | INSRR | 1.01788846 |
| 58 | MAP3K7 | 0.97462284 |
| 59 | EPHB1 | 0.96301475 |
| 60 | MAPKAPK5 | 0.94416997 |
| 61 | TBK1 | 0.93477865 |
| 62 | MAPK11 | 0.91659959 |
| 63 | EEF2K | 0.91232807 |
| 64 | STK38L | 0.89352327 |
| 65 | MAP3K3 | 0.89181228 |
| 66 | PIK3CG | 0.88409318 |
| 67 | CAMK1D | 0.86837861 |
| 68 | TAOK3 | 0.86610971 |
| 69 | PRKD1 | 0.84737913 |
| 70 | PTK6 | 0.84501134 |
| 71 | MAPK12 | 0.84408014 |
| 72 | CAMK1 | 0.84364817 |
| 73 | RIPK1 | 0.84321332 |
| 74 | PRKAA1 | 0.83877768 |
| 75 | TYK2 | 0.83705825 |
| 76 | GRK7 | 0.83131410 |
| 77 | LRRK2 | 0.82783475 |
| 78 | MAPKAPK3 | 0.81026311 |
| 79 | ADRBK1 | 0.80651599 |
| 80 | NLK | 0.78999375 |
| 81 | TNK2 | 0.78057824 |
| 82 | TRPM7 | 0.77629945 |
| 83 | STK38 | 0.75542743 |
| 84 | PRKG1 | 0.73271769 |
| 85 | SGK223 | 0.72098658 |
| 86 | SGK494 | 0.72098658 |
| 87 | PRKCG | 0.69343385 |
| 88 | TNIK | 0.67383935 |
| 89 | MKNK2 | 0.65987248 |
| 90 | STK4 | 0.63799375 |
| 91 | PDPK1 | 0.62995788 |
| 92 | ABL2 | 0.62757044 |
| 93 | BRSK2 | 0.60988739 |
| 94 | MAP3K5 | 0.59749260 |
| 95 | MAP3K4 | 0.59269366 |
| 96 | CAMK2D | 0.56605565 |
| 97 | PRKG2 | 0.55969250 |
| 98 | JAK2 | 0.55664626 |
| 99 | JAK1 | 0.54461711 |
| 100 | PKN1 | 0.53049569 |
| 101 | TEC | 0.52488456 |
| 102 | MAP3K2 | 0.51595132 |
| 103 | GRK5 | 0.51518904 |
| 104 | PTK2B | 0.51354194 |
| 105 | PRKACG | 0.51158068 |
| 106 | BCR | 0.50043466 |
| 107 | ZAK | 0.48197966 |
| 108 | PDK1 | 0.48027373 |
| 109 | EPHA4 | 0.47660077 |
| 110 | MAP2K4 | 0.46577231 |
| 111 | IGF1R | 0.46383213 |
| 112 | DYRK2 | 0.46184068 |
| 113 | EPHB2 | 0.46114968 |
| 114 | MAP3K11 | 0.45890668 |
| 115 | CAMK2A | 0.45820557 |
| 116 | PRKCZ | 0.45171987 |
| 117 | MAPK7 | 0.43687905 |
| 118 | MAP2K1 | 0.43247746 |
| 119 | CDK4 | 0.43123129 |
| 120 | PAK3 | 0.42792508 |
| 121 | SGK1 | 0.41427403 |
| 122 | ERBB2 | 0.41240401 |
| 123 | KIT | 0.39685150 |
| 124 | MAP2K7 | 0.39563735 |
| 125 | STK11 | 0.39505083 |
| 126 | ROCK1 | 0.38892024 |
| 127 | PLK2 | 0.37796136 |
| 128 | EPHA3 | 0.37167517 |
| 129 | HIPK2 | 0.36575355 |
| 130 | DAPK3 | 0.36452958 |
| 131 | MAPK4 | 0.36126547 |
| 132 | FGFR3 | 0.35776512 |
| 133 | RPS6KA3 | 0.34935221 |
| 134 | SGK3 | 0.34868602 |
| 135 | PDGFRA | 0.34505658 |
| 136 | STK3 | 0.32794140 |
| 137 | JAK3 | 0.32294558 |
| 138 | CAMK4 | 0.31630338 |
| 139 | AKT2 | 0.31406797 |
| 140 | STK39 | 0.30789040 |
| 141 | IRAK3 | 0.29973403 |
| 142 | MAP2K2 | 0.29951872 |
| 143 | PIM2 | 0.29629393 |
| 144 | CAMK2G | 0.29230820 |
| 145 | LATS1 | 0.29182296 |
| 146 | CDK6 | 0.29077364 |
| 147 | TGFBR1 | 0.28336856 |
| 148 | MAP4K1 | 0.26370583 |
| 149 | RPS6KL1 | 0.25292050 |
| 150 | RPS6KC1 | 0.25292050 |
| 151 | RPS6KA6 | 0.25165288 |
| 152 | ZAP70 | 0.24390408 |
| 153 | GSK3A | 0.24220524 |
| 154 | MAP2K6 | 0.22276058 |
| 155 | PRKACB | 0.21713174 |
| 156 | MTOR | 0.20577410 |
| 157 | RET | 0.19898676 |
| 158 | PRKACA | 0.19898582 |
| 159 | MET | 0.19687016 |
| 160 | STK10 | 0.19040282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.55848240 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.88001883 |
| 3 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.68624498 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.68162574 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.48743042 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.97414987 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.88485044 |
| 8 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.84649907 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.50078069 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32202514 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.23864120 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23000764 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20052726 |
| 14 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.18656827 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02710034 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.00053059 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.94095007 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.90749672 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.86299562 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85307218 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83732308 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74259600 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56342972 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.51518194 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.50621193 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47535199 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43591609 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39537402 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34190229 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33718523 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.27818429 |
| 32 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22096767 |
| 33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17996600 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17368351 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13654547 |
| 36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.12793325 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11332342 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08286847 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07132792 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01857222 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01380683 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99268979 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97860783 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97142172 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93995322 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92521039 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92035410 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90506723 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90452986 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88833079 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87431628 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87321717 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86649240 |
| 54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86239526 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.85517564 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.84597811 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82974955 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81930160 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80912722 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80743407 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80414822 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77037540 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76635387 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75567535 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72909191 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72613763 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72559924 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.71836278 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71246022 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69023498 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.68963900 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67109757 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.65831864 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65334989 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61370705 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58960455 |
| 77 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56174306 |
| 78 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52083618 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51682862 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50704440 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49188077 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45195095 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43767076 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42283393 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42232906 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41892847 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.41380886 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40952039 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38893648 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37647930 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34928940 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.34716298 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33648388 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31354551 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31045731 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.29701855 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28613878 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.25924445 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.24785110 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23649298 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.22759094 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.22393542 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.21956753 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.21027808 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.20110036 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.19743324 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18846691 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.18285266 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17411588 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15741215 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15012872 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13032684 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.07880732 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.07619900 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05428488 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.04518465 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.03204491 |
| 118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.01546656 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.00516482 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0658241 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | -0.0630848 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0599855 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | -0.0580975 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | -0.0547281 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0354798 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0188903 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0122797 |

